Thrombosis with associated inflammation (thromboinflammation) occurs commonly in a
broad range of human disorders. It is well recognized clinically in the context of superficial …

Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …

Objective Systemic immune-inflammation index (SII), on the basis of lymphocyte, neutrophil
and platelet counts had been published to be a good prognostic factor in coronary artery …

The aim of the study was to evaluate the utility of the preprocedural platelet–lymphocyte ratio
(PLR) for predicting no reflow in patients undergoing primary percutaneous intervention …

Background The ratio of serum C‐reactive protein (CRP) to albumin has been proven to be
a more accurate indicator than albumin and CRP levels alone in determining the prognosis …

Although mean platelet volume (MPV) is an independent correlate of impaired angiographic
reperfusion and 6-month mortality in ST-segment elevation myocardial infarction (STEMI) …

Microthrombosis plays a key role in many cardiovascular diseases. Although it is not difficult
to localize thrombus within large or middle-sized vessels, the noninvasive diagnostic …

Vagal nerve stimulation (VNS) started prior to, or during, ischemia has been shown to
reduce infarct size. Here, we investigated the effect of VNS when started just prior to, and …

No-reflow is one of the major complications of primary percutaneous coronary artery
intervention (pPCI) in the treatment of acute ST-segment elevation myocardial infarction …

Noreflow is a condition associated with a poor prognosis in ST segment elevation
myocardial infarction patients. It has been shown that many inflammatory markers and index …